38 minutes |
17 days ago
The Alderley Park Discovery Podcast: Life science skills, staffing and support
17 minutes |
a month ago
J&J and medical device innovation: the pharmaphorum podcast
18 minutes |
2 months ago
Biotech trends in COVID era: the pharmaphorum podcast
13 minutes |
3 months ago
GSK and eosinophil research: the pharmaphorum podcast
16 minutes |
4 months ago
Gitte Aabo on telemedicine and her time at LEO Pharma: the pharmaphorum podcast
23 minutes |
4 months ago
The Alderley Park Discovery Podcast: COVID testing and the Lighthouse Lab
19 minutes |
5 months ago
Alnylam, gene-silencing and biotech in 2020: the pharmaphorum podcast
20 minutes |
6 months ago
Novartis, company culture and COVID-19: the pharmaphorum podcast
22 minutes |
7 months ago
Amgen and science education: the pharmaphorum podcast
21 minutes |
8 months ago
UK pharma leadership and COVID-19: the pharmaphorum podcast
14 minutes |
10 months ago
Eisai and Alexa skills in epilepsy: the pharmaphorum podcast
21 minutes |
10 months ago
Digital health and interoperability: the pharmaphorum podcast
32 minutes |
a year ago
Roche, big data and patient outcomes: the pharmaphorum podcast
29 minutes |
a year ago
Pfizer and the UK cancer landscape: the pharmaphorum podcast
43 minutes |
a year ago
Life sciences leadership: the pharmaphorum podcast
22 minutes |
a year ago
AstraZeneca and lung cancer: the pharmaphorum podcast
26 minutes |
a year ago
Lung cancer’s patient information gap: the pharmaphorum podcast
59 minutes |
2 years ago
Addressing global health challenges: the pharmaphorum podcast
20 minutes |
2 years ago
Gene therapy and market access: the pharmaphorum podcast
24 minutes |
2 years ago
AMR research and Matoke Pharma: the pharmaphorum podcast